“Poorly differentiated” refers to cancer cells that have more abnormalities and look less like normal cancer cells. Poorly differentiated thyroid cancer is uncommon, accounting for fewer than 5% of ...

"well-differentiated" means the cancer cells resemble the normal cells from which they grew. Well-differentiated cancers grow more slowly and have a better prognosis than undifferentiated cancers, ...

Radioiodine therapy was non-inferior to no radioiodine therapy after thyroidectomy among patients with low-risk differentiated thyroid cancer.

Please confirm that you would like to log out of Medscape. If you log out, you will be required to enter your username and password the next time you visit. Log out ...

Treatment of thyroid nodules and differentiated thyroid cancer can generally be safely postponed until after delivery. As diagnosing thyroid diseases during pregnancy may be difficult, adequate ...

Detection of thyroglobulin in the needle aspirates of nonthyroidal neck masses: a clue to the diagnosis of metastatic differentiated thyroid cancer. J. Clin. Endocrinol. Metab. 74, 1401–1404 (1992).

The case comes from a phase 1 study of its ICAM-1 targeting CAR-T autologous candidate AIC100 in patients with relapsed/refractory poorly differentiated thyroid cancer (PDTC) and anaplastic ...

Lenvatinib mesylate is under clinical development by Eisai and currently in Phase I for Epithelial Ovarian Cancer.

Sacituzumab govitecan is under clinical development by Gilead Sciences and currently in Phase II for Anaplastic Thyroid Cancer.

Referral is less common in patients with well-differentiated carcinoma ... the potential inhibitory effect of the RTKI on the thyroid cancer cells. In light of these observations, it is vital ...